Primary Record
Nocardicin A
- In stock
- 8,334 g
- Purity
- 98.9 %
- CAS
- 39391-39-4
Compound Identifiers & Properties
- CAS
- 39391-39-4
- PubChem CID
- 6400657
- SMILES
- C1[C@@H](C(=O)N1[C@H](C2=CC=C(C=C2)O)C(=O)O)NC(=O)/C(=N\O)/C3=CC=C(C=C3)OCC[C@H](C(=O)O)N
- Canonical SMILES
- N[C@H](CCOc1ccc(/C(=N/O)C(=O)N[C@H]2CN([C@@H](C(=O)O)c3ccc(O)cc3)C2=O)cc1)C(=O)O
Names & Synonyms
- Nocardicin A
- nocarcidins
- Nocardicin
- Isonocardicin A
- Nocardicin B
- Antibiotic FR 1923
- Antibiotic FR 2458
- ANTIBIOTIC FR-1923
- RefChem:166270
- R76HLW7Z19
- UNII-R76HLW7Z19
- NOCARDICIN A [MI]
- UNII-QWV6T6M34F
- 39391-39-4
- AC1O46UO
- CHEBI:17711
- DTXSID201028178
- orb1701864
- SCHEMBL1442259
- GTPL12295
- FR-1923-C
- C23H24N4O9
- DTXCID101513762
- GLXC-04635
- FR-1923C
- BBF-02607
- AKOS040747216
- C23-H24-N4-O9
- ZINC100584958
- CID6400657
- FR-1923
- FR-2458
- BRN 3599648
- J17.397E
- HY-117108
- C01941
- Q27893746
- (2R)-2-Amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-hydroxycarbonimidoyl]phenoxy]butanoic acid
- O-{4-[(1Z)-2-{(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-ylamino}-N-hydroxy-2-oxoethanimidoyl]phenyl}-D-homoserine
- (.ALPHA.R,3S)-3-(((2Z)-(4-((3R)-3-AMINO-3-CARBOXYPROPOXY)PHENYL)(HYDROXYIMINO)ACETYL)AMINO)-.ALPHA.-(4-HYDROXYPHENYL)-2-OXO-1-AZETIDINEACETIC ACID
- (2R)-2-amino-4-(4-((Z)-C-(((3S)-1-((R)-carboxy-(4-hydroxyphenyl)methyl)-2-oxoazetidin-3-yl)carbamoyl)-N-hydroxycarbonimidoyl)phenoxy)butanoic acid
- (2R)-2-amino-4-(4-(N-hydroxy-C-(((3S)-1-((1R)-2-hydroxy-1-(4-hydroxyphenyl)-2-oxoethyl)-2-oxoazetidin-3-yl)carbamoyl)carbonimidoyl)phenoxy)butanoic acid
- (2R)-2-amino-4-[4-[(Z)-N-hydroxy-C-[[(3S)-1-[(1R)-2-hydroxy-1-(4-hydroxyphenyl)-2-oxoethyl]-2-oxoazetidin-3-yl]carbamoyl]carbonimidoyl]phenoxy]butanoic acid
- (2R)-2-amino-4-[4-[N-hydroxy-C-[[(3S)-1-[(1R)-2-hydroxy-1-(4-hydroxyphenyl)-2-oxoethyl]-2-oxoazetidin-3-yl]carbamoyl]carbonimidoyl]phenoxy]butanoic acid
- (2R)-2-amino-4-{4-[(Z)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoic acid
- (3S,alphaR)-3-[[[4-[(R)-3-Amino-3-carboxypropoxy]phenyl]-[(Z)-hydroxyimino]acetyl]amino]-alpha-(4-hydroxyphenyl)-2-oxo-1-azetidineacetic acid
- (3S,alphaR)-3beta-[[[4-[(3R)-3-Amino-3-carboxypropoxy]phenyl][(Z)-hydroxyimino]acetyl]amino]-alpha-(4-hydroxyphenyl)-2-oxo-1-azetidineacetic acid
- 1-AZETIDINEACETIC ACID, 3-(((2Z)-2-(4-((3R)-3-AMINO-3-CARBOXYPROPOXY)PHENYL)-2-(HYDROXYIMINO)ACETYL)AMINO)-.ALPHA.-(4-HYDROXYPHENYL)-2-OXO-, (.ALPHA.R,3S)-C4375
- 1-Azetidineacetic acid, 3-(((4-(3-amino-3-carboxypropoxy)phenyl)(hydroxyimino)acetyl)amino)-alpha-(4-hydroxyphenyl)-2-oxo-, (3S-(1(S*),3R*(Z(S*))))-
- 1-Azetidineacetic acid, 3-[[[4-(3-amino-3-carboxypropoxy)phenyl](hydroxyimino)acetyl]amino]-.alpha.-(4-hydroxyphenyl)-2-oxo-, [3S-[1(S*),3R*[Z(S*)]]]-
- 60134-71-6
- O-(4-((1Z)-2-((3S)-1-((R)-carboxy(4-hydroxyphenyl)methyl)-2-oxoazetidin-3-ylamino)-N-hydroxy-2-oxoethanimidoyl)phenyl)-D-homoserine